Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

New drug offered to addicted inmates combats opioid epidemic

Duration: 03:46s - Published: < > Embed
News video: New drug offered to addicted inmates combats opioid epidemicA new program fighting opiate addiction among inmates at a Kentucky jail combines the traditional tools of recovery, psychotherapy and 12-step support groups with a new drug, Vivitrol. It blocks the effects of opiates like heroin and morphine. Jim Axelrod reports.

0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Innate Immunotherapeutics’ new drug application gets cleared by FDA

Innate Immunotherapeutics (ASX:IIL) has received clearance from the U.S. FDA for the Investigational...
Proactive Investors - Business

Correction: China-Carfentanil story

The U.S. Drug Enforcement Administration called China's move a potential "game-changer" that is...
SeattlePI.com - Technology

New antibiotic effective against drug-resistant bacteria

Scientists have discovered a new antibiotic effective against drug-resistant bacteria:...
Science Daily - Science

Clovis Oncology to raise US$250mln to build on ovarian cancer trial success

Clovis Oncology Inc (NASDAQ:CLVS) is wasting no time in raising funds for its application for ovarian...
Proactive Investors - Business

New genetic technique could help identify potential drug targets for malaria

Scientists have developed a new technique for investigating the effects of gene deletion at later...
Science Daily - Science


You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+